Janus Henderson Group
MYGN icon

Janus Henderson Group’s Myriad Genetics MYGN Stock Holding History

Janus Henderson Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178K Hold
39,469
– – ﹤0.01% 2346
2025
Q4 		$243K Hold
39,469
– – ﹤0.01% 2289
2025
Q3 		$285K Hold
39,469
– – ﹤0.01% 2226
2025
Q2 		$209K Hold
39,469
– – ﹤0.01% 2305
2025
Q1 		$350K Hold
39,469
– – ﹤0.01% 2138
2024
Q4 		$541K Hold
39,469
– – ﹤0.01% 1996
2024
Q3 		$1.08M Hold
39,469
– – ﹤0.01% 1626
2024
Q2 		$965K Sell
39,469
-408
-1% -$8.95K ﹤0.01% 1638
2024
Q1 		$849K Buy
39,877
+1
+0% +$21 ﹤0.01% 1731
2023
Q4 		$763K Sell
39,876
-60
-0.2% -$1.04K ﹤0.01% 1783
2023
Q3 		$640K Buy
39,936
+6
+0% +$114 ﹤0.01% 1804
2023
Q2 		$925K Sell
39,930
-41
-0.1% -$895 ﹤0.01% 1648
2023
Q1 		$927K Buy
39,971
+24,682
+161% +$501K ﹤0.01% 1674
2022
Q4 		$222K Sell
15,289
-1
-0% -$19 ﹤0.01% 2139
2022
Q3 		$292K Buy
15,290
+15
+0.1% +$344 ﹤0.01% 1770
2022
Q2 		$278K Sell
15,275
-11
-0.1% -$228 ﹤0.01% 2123
2022
Q1 		$384K Buy
15,286
+13
+0.1% +$333 ﹤0.01% 2064
2021
Q4 		$422K Buy
15,273
+7,682
+101% +$223K ﹤0.01% 1998
2021
Q3 		$245K Buy
+7,591
New +$252K ﹤0.01% 1983

Other funds holding MYGN

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janus Henderson Group's MYGN Position: Q1 2026 in Review

Janus Henderson Group held its Myriad Genetics (MYGN) position steady in Q1 2026 at 39,469 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

Janus Henderson Group first reported a position in MYGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.08M in Q3 2024. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Janus Henderson Group held 39,469 shares of Myriad Genetics worth $178K as of Q1 2026.
  • Janus Henderson Group left its Myriad Genetics share count unchanged in Q1 2026.
  • Myriad Genetics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2346 holding.
  • Janus Henderson Group first reported a position in Myriad Genetics in Q3 2021 and has held it in 19 quarters since.
  • Janus Henderson Group's Myriad Genetics position peaked at $1.08M in Q3 2024.
  • 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.